Status: Recruiting
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
Participants needed: 741
Trial details
Phase: Phase 4Age: 65+Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: Apr 7, 2026Locations: 10
Eligibility criteria
Age ≥65 years [+6]
Current taking (both) a beta-blocker AND a calcium channel blocker* [+19]